As anticipated, among females with BC and OC (n = 1022), PVs were most frequent in BRCA1 (8.6%, 95% CI 7.0–10.5%) and BRCA2 (5.8%, 95% CI 4.5–7.4%). This evidence concerns the gene BRCA1 and breast cancer.